Facilitating the collaboration between the basic, translational, and clinical sciences, this book provides an overview of the genetic and epigenetic mechanisms underlying the formation and progression of gynecological cancers. Gynecological Cancers: Genetic and Epigenetic Targets and Drug Development gathers all of the molecular and cellular aspects of gynecological cancer together within one volume, providing detailed and up-to-date information on the etiology, diagnosis, and treatment of gynecological cancers.
Gynecological Cancers: Genetic and Epigenetic Targets and Drug Development also discusses the racial and ethnic disparities in the treatment of gynecological cancers through cost effective modalities like single visit screening and diagnosis, well women clinics, and mobile clinics. Written and edited by leaders in the field, this volume within the Current Clinical Oncology series is an indispensable resource for today’s practicing oncologist.
Gynecological Cancers: Genetic and Epigenetic Targets and Drug Development also discusses the racial and ethnic disparities in the treatment of gynecological cancers through cost effective modalities like single visit screening and diagnosis, well women clinics, and mobile clinics. Written and edited by leaders in the field, this volume within the Current Clinical Oncology series is an indispensable resource for today’s practicing oncologist.
Les mer
Facilitating the collaboration between the basic, translational, and clinical sciences, this book provides an overview of the genetic and epigenetic mechanisms underlying the formation and progression of gynecological cancers.
Les mer
I. Epigenetic Mechanisms in Gynecological Cancers.- 1.Epigenetic Mechanisms in Gynecological Cancer.- 2.Pharmacoepigenomics and Pharmacovigilance in Gynecological Cancers.- II. Current Standard of Care for the Treatment of Gynecological Tumors.- 3.Advances in Cervical Cancer and Ongoing Clinical Trials.- 4.Advances in Ovarian Cancer and Ongoing Clinical Trials.- 5.Novel Methods for Prevention and Early Diagnosis of Ovarian and Endometrial Cancers.- III. Gynecological Cancers: New Therapies, Drug Development, and Challenges.- 6.Developmental Therapeutics for Gynecologic Cancers: An Overview.- IV. Fertility Preservation in the Setting of Malignant Disease.- 7.Preservation of Fertility in Gynecological Malignancies.- V. Racial/Ethnic Disparities in Gynecological Cancer Screening, Treatment and Survival.- 8.Racial/Ethnic Disparities in Gynecological Cancer Screening, Treatment and Survival.
Les mer
Facilitating the collaboration between the basic, translational, and clinical sciences, this book provides an overview of the genetic and epigenetic mechanisms underlying the formation and progression of gynecological cancers. Gynecological Cancers: Genetic and Epigenetic Targets and Drug Development gathers all of the molecular and cellular aspects of gynecological cancer together within one volume, providing detailed and up-to-date information on the etiology, diagnosis, and treatment of gynecological cancers.
Gynecological Cancers: Genetic and Epigenetic Targets and Drug Development also discusses the racial and ethnic disparities in the treatment of gynecological cancers through cost effective modalities like single visit screening and diagnosis, well women clinics, and mobile clinics. Written and edited by leaders in the field, this volumewithin the Current Clinical Oncology series is an indispensable resource for today’s practicing oncologist.
Gynecological Cancers: Genetic and Epigenetic Targets and Drug Development also discusses the racial and ethnic disparities in the treatment of gynecological cancers through cost effective modalities like single visit screening and diagnosis, well women clinics, and mobile clinics. Written and edited by leaders in the field, this volumewithin the Current Clinical Oncology series is an indispensable resource for today’s practicing oncologist.
Les mer
Provides detailed and up-to-date information on the etiology, diagnosis, and treatment of gynecological cancers Discusses the diagnosis and treatment of gynecological cancers, including ovarian cancer, uterine cancer, cervical cancer, vaginal cancer, and vulvar cancer Provides an overview of the genetic and epigenetic mechanisms underlying the formation and progression of gynecological cancers Discusses cutting-edge bio-molecular approaches to cancer therapy Offers an up-to-date molecular and therapeutic link, facilitating the collaboration between the basic, translational, and clinical services Discusses the racial/ethnic disparities in screening, treatment, and survival? Written for research and clinical oncologists, translational cancer scientists, medical and biomedical students
Les mer
GPSR Compliance
The European Union's (EU) General Product Safety Regulation (GPSR) is a set of rules that requires consumer products to be safe and our obligations to ensure this.
If you have any concerns about our products you can contact us on ProductSafety@springernature.com.
In case Publisher is established outside the EU, the EU authorized representative is:
Springer Nature Customer Service Center GmbH
Europaplatz 3
69115 Heidelberg, Germany
ProductSafety@springernature.com
Les mer
Produktdetaljer
ISBN
9783319329055
Publisert
2016-07-26
Utgiver
Springer International Publishing AG
Høyde
254 mm
Bredde
178 mm
Aldersnivå
Professional/practitioner, P, 06
Språk
Product language
Engelsk
Format
Product format
Innbundet
Antall sider
173
Biografisk notat
Antonio Giordano, MD, PhDProfessorTemple UniversitySbarro Institute for Cancer Research and Molecular Medicine and Center of BiotechnologyDepartment of BiologyPhiladelphia, PA, USAMarcella Macaluso, PhDAssociate ProfessorTemple UniversitySbarro Institute for Cancer Research and Molecular Medicine and Center of BiotechnologyDepartment of BiologyPhiladelphia, PA, USA